Benjamin Looker - Jan 18, 2023 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
General Counsel
Signature
/s/ Sheldon L. Koenig, by power of attorney
Stock symbol
ESPR
Transactions as of
Jan 18, 2023
Transactions value $
-$44,404
Form type
4
Date filed
1/19/2023, 03:58 PM
Previous filing
Jun 9, 2022
Next filing
Mar 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale -$44.4K -6.35K -8.96% $7.00 64.5K Jan 18, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on vested shares of restricted stock units.